BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang D, Li L, Chen Y, Ma J, Yang Y, Aodeng S, Cui Q, Wen K, Xiao M, Xie J, Xu Y, Li Y. Syndecan-1, an indicator of endothelial glycocalyx degradation, predicts outcome of patients admitted to an ICU with COVID-19. Mol Med 2021;27:151. [PMID: 34861818 DOI: 10.1186/s10020-021-00412-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Koike T, Fujii K, Kometani K, Butler NS, Funakoshi K, Yari S, Kikuta J, Ishii M, Kurosaki T, Ise W. Progressive differentiation toward the long-lived plasma cell compartment in the bone marrow. Journal of Experimental Medicine 2023;220. [DOI: 10.1084/jem.20221717] [Reference Citation Analysis]
2 Tuculeanu G, Barbu EC, Lazar M, Chitu-Tisu CE, Moisa E, Negoita SI, Ion DA. Coagulation Disorders in Sepsis and COVID-19-Two Sides of the Same Coin? A Review of Inflammation-Coagulation Crosstalk in Bacterial Sepsis and COVID-19. J Clin Med 2023;12. [PMID: 36675530 DOI: 10.3390/jcm12020601] [Reference Citation Analysis]
3 Zhang Q, Ye Z, Bignotti A, Zheng XL. Longitudinal Assessment of Plasma Syndecan-1 Predicts 60-Day Mortality in Patients with COVID-19. J Clin Med 2023;12. [PMID: 36675479 DOI: 10.3390/jcm12020552] [Reference Citation Analysis]
4 Asif S, Frithiof R, Larsson A, Franzén S, Anderberg SB, Kristensen B, Hultström M, Lipcsey M. Immuno-Modulatory Effects of Dexamethasone in Severe COVID-19-A Swedish Cohort Study. Biomedicines 2023;11. [PMID: 36672672 DOI: 10.3390/biomedicines11010164] [Reference Citation Analysis]
5 Munguía L, Nájera N, Martínez FJ, Díaz-Chiguer D, Jiménez-Ponce F, Ortiz-Flores M, Villarreal F, Ceballos G. Correlation of Biomarkers of Endothelial Injury and Inflammation to Outcome in Hospitalized COVID-19 Patients. J Clin Med 2022;11. [PMID: 36556051 DOI: 10.3390/jcm11247436] [Reference Citation Analysis]
6 Quan Zhang, Zhan Ye, Paul McGowan, Christopher Jurief, Andrew Ly, Antonia Bignotti, Noritaka Yada, X. Long Zheng. Effects of convalescent plasma infusion on the ADAMTS13-von Willebrand factor axis and endothelial integrity in patients with severe and critical COVID-19. Res Pract Thromb Haemost 2022:100010. [PMID: 36531671 DOI: 10.1016/j.rpth.2022.100010] [Reference Citation Analysis]
7 Pretorius D, Richter RP, Anand T, Cardenas JC, Richter JR. Alterations in heparan sulfate proteoglycan synthesis and sulfation and the impact on vascular endothelial function. Matrix Biol Plus 2022;16:100121. [PMID: 36160687 DOI: 10.1016/j.mbplus.2022.100121] [Reference Citation Analysis]
8 Harriott NC, Ryan AL. Proteomic profiling identifies biomarkers of COVID-19 severity.. [DOI: 10.1101/2022.11.29.518411] [Reference Citation Analysis]
9 Kozłowski P, Śmiarowski M, Przyborska W, Zemlik K, Małecka-giełdowska M, Leszczyńska A, Garley M, Ciepiela O. Mild-to-Moderate COVID-19 Convalescents May Present Pro-Longed Endothelium Injury. JCM 2022;11:6461. [DOI: 10.3390/jcm11216461] [Reference Citation Analysis]
10 Xu SW, Ilyas I, Weng JP. Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies. Acta Pharmacol Sin 2022. [PMID: 36253560 DOI: 10.1038/s41401-022-00998-0] [Reference Citation Analysis]
11 Patterson EK, Cepinskas G, Fraser DD. Endothelial Glycocalyx Degradation in Critical Illness and Injury. Front Med (Lausanne) 2022;9:898592. [PMID: 35872762 DOI: 10.3389/fmed.2022.898592] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Yang D, Li H, Chen Y, Ren W, Dong M, Li C, Jiao Q. Immunomodulatory mechanisms of abatacept: A therapeutic strategy for COVID-19. Front Med 2022;9. [DOI: 10.3389/fmed.2022.951115] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Mourouzis I, Apostolaki V, Trikas A, Kokkinos L, Alexandrou N, Avdikou M, Giannoulopoulou M, Vassi A, Tseti I, Pantos C. The Potential of Thyroid Hormone Therapy in Severe COVID-19: Rationale and Preliminary Evidence. IJERPH 2022;19:8063. [DOI: 10.3390/ijerph19138063] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Zha D, Fu M, Qian Y. Vascular Endothelial Glycocalyx Damage and Potential Targeted Therapy in COVID-19. Cells 2022;11:1972. [PMID: 35741101 DOI: 10.3390/cells11121972] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]